Bibliographic information
GuidelineMedical eligibility criteria for contraceptive use, 6th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization
Recommendation
Updated
Women living with HIV and using antiretroviral therapy (ART). Women using Non-nucleoside/ nucleotide reverse transcriptase inIhibitors (NNRTIs) containing efavirenz can use progestogenonly injectables (POIs) (depot medroxyprogesterone acetate [DMPA] without restriction
Certainty of evidence
Very low